
Musculoskeletal Complications of Hemophilia: The Joint – Japanese
Also Available In: English, Spanish, Arabic This is not an official WFH translation. This resource has been translated with permission
Year: 2018
Language: Traditional Chinese
Author(s): Jenny Goudemand, Manuel Carcao
Format: Document
Also Available In: English, Spanish
This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for any errors or changes to content from the original English edition. Patient organizations interested in translating a WFH resource must first obtain permission from the WFH, available here.
Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of how and why inhibitors form, reviews the established approaches to managing inhibitors, and looks ahead to some potential future developments in the field.

Also Available In: English, Spanish, Arabic This is not an official WFH translation. This resource has been translated with permission